Byron Robinson

Byron Robinson

Corporate Officer/Principal at JANUX THERAPEUTICS, INC.

Net worth: - $ as of 29/04/2024

59 year
Health Technology
Consumer Services
Health Services

Profile

Byron Robinson is currently the Chief Strategy Officer at Janux Therapeutics, Inc. Prior to this, he worked as a Manager-Global Project at Amgen, Inc. from 2002 to 2012 and as the Head-Chemistry Research & Development at Miravant Medical Technologies from 1992 to 2002.
He also held positions at Merck KGaA and Bayer HealthCare.
Dr. Robinson received his undergraduate and doctorate degrees from the University of New England and his graduate degree from Santa Barbara & Ventura Colleges of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/01/2024 0 ( -.--% ) - $ 29/04/2024

Byron Robinson active positions

CompaniesPositionStart
JANUX THERAPEUTICS, INC. Corporate Officer/Principal 28/02/2022
All active positions of Byron Robinson

Former positions of Byron Robinson

CompaniesPositionEnd
Corporate Officer/Principal 30/04/2016
AMGEN INC. Corporate Officer/Principal 30/11/2012
MIRAVANT MEDICAL TECHNOLOGIES INC. Corporate Officer/Principal 30/09/2002
MERCK KGAA Corporate Officer/Principal -
See the detail of Byron Robinson's experience

Training of Byron Robinson

University of New England Doctorate Degree
Santa Barbara & Ventura Colleges of Law Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Byron Robinson's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
JANUX THERAPEUTICS, INC.

Health Technology

MERCK KGAA

Health Technology

AMGEN INC.

Health Technology

MIRAVANT MEDICAL TECHNOLOGIES INC.

Health Technology

Private companies1

Health Services

See company connections
  1. Stock Market
  2. Insiders
  3. Byron Robinson